Expert Ratings for Aveanna Healthcare Hldgs
Over the past 3 months, 4 analysts have published their opinion on Aveanna Healthcare Hldgs (NASDAQ:AVAH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $5
Barclays analyst Sarah James maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $7 to $5.
This Analyst Boosts Price Target On Dillard’s; Also Check Out Some Other Big PT Changes
JP Morgan raised the price target for Dillard's, Inc. (NYSE: DDS) from $210 to $298. Dillard's shares rose 0.9% to $304.42 in pre-market trading.
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Lowers Price Target to $6
Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and lowers the price target from $8 to $6.
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
Aveanna Healthcare Earnings Outlook
Aveanna Healthcare Hldgs (NASDAQ:AVAH) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 120 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 61 companies made new 52-week lows.